« Previous
Next »
Titles
- Antiandrogen therapies for nonmetastatic castration-resistant prostate cancer: effectiveness and value : final evidence report1
- Are you ready to respond?: reports of high harm complications after surgery and invasive procedures1
- Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report1
- Calcitonin gene-related peptide (CGRP) inhibitors as preventive treatments for patients with episodic or chronic migraine: effectiveness and value : final evidence report1
- Chimeric antigen receptor T-cell therapy for B-cell cancers: effectiveness and value : final evidence report1
- Cognitive and mind-body therapies for chronic low back and neck pain: effectiveness and value : final evidence report1
- Controversies in migraine management: a technology assessment : final report1
- Controversies in the management of patients with type 2 diabetes: final report1
- Disease-modifying therapies for relapsing-remitting and primary-progressive multiple sclerosis: effectiveness and value : final evidence report1
- Dupilumab and crisaborole for atopic dermatitis: effectiveness and value : final evidence report and meeting summary1
- Elagolix for treating endometriosis: final evidence report1
- Emicizumab for hemophilia A with inhibitors: effectiveness and value : final evidence report1
- Evidence-informed case rates: a new health care payment model1
- Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report1
- Health care without the doctor: how new devices and technologies aid clinicians and consumers1
- Indications for and management of inferior vena cava filters1
- Inotersen and patisiran for hereditary transthyretin amyloidosis: effectiveness and value : final evidence report1
- Management of patients with opioid dependence: a review of clinical, delivery system, and policy options1
- Modulator treatments for cystic fibrosis: effectiveness and value : final evidence report and meeting summary1
- Obeticholic acid for the treatment of primary biliary cholangitis: comparative clinical effectiveness, value, and value-based price benchmarks : evidence report1